发明申请
US20120064092A1 Novel Target for Regulating Multiple Sclerosis 审中-公开
调节多发性硬化的新目标

Novel Target for Regulating Multiple Sclerosis
摘要:
Methods are provided for decreasing demyelinating inflammatory disease in a subject by inhibiting the activity of chemokine-like receptor 1 (CMKLR1). Methods are also provided for screening for agents that find use in treating demyelinating inflammatory disease in a subject.
信息查询
0/0